StockNews.AI · 3 hours
Stryker announced the US commercial launch of Mako RPS, a handheld robotic system for total knee replacement, expanding the Mako platform beyond robotic-arm surgery. The new platform blends robotic execution with intraoperative planning and a familiar handheld workflow, potentially broadening adoption across more care settings. The catalyst could lift near-term robotics revenue and hardware sales for SYK.
Introducing a handheld robotics option (RPS) could accelerate adoption, expand addressable settings, and drive near-term hardware/software revenue; similar product line expansions historically boost top-line robotics growth and related services when integrated with established platforms.
Bullish on SYK near-term as Mako RPS expands the robotics addressable market; uptake could accelerate within 6–12 months.
Industry News / Corporate Developments: This is a strategic product expansion that broadens SYK's robotics portfolio and could influence adoption and mix in orthopaedic robotics.